CORDIS
EU research results

CORDIS

English EN

Optimization of Medical Accelerators

Objective

Cancer is a major social problem, and it is the main cause of death between the ages 45-65 years. In the treatment of cancer, radio therapy (RT) plays an essential role. RT with hadrons (protons and light ions), due to their unique physical and radiobiological properties, offers several advantages over photons for specific cancer types. In particular, they penetrate the patient with minimal diffusion, they deposit maximum energy at the end of their range, and they can be shaped as narrow focused and scanned pencil beams of variable penetration depth. Although significant progress has been made in the use of particle beams for cancer treatment, an extensive research and development program is still needed to maximize the healthcare benefits from these therapies.
The Optimization of Medical Accelerators (OMA) is the aim of the here-proposed European Training Network, in line with the requirements of the EC’s Medical Exposure Directive. OMA joins universities, research centers and clinical facilities with industry partners to address the challenges in treatment facility design and optimization, numerical simulations for the development of advanced treatment schemes, and in beam imaging and treatment monitoring.
The proposed R&D program ranges from life sciences (oncology, cell and micro biology and medical imaging.), physics and accelerator sciences, mathematics and IT, to engineering. It is hence ideally suited for an innovative training of early stage researchers. By closely linking all above research areas, OMA will provide an interdisciplinary education to its Fellows. This will equip them with solid knowledge also in research areas adjacent to their core research field, as well as with business competences and hence give them a perfect basis for a career in research.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

THE UNIVERSITY OF LIVERPOOL

Address

Brownlow Hill 765 Foundation Building
L69 7zx Liverpool

United Kingdom

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 273 287,88

Participants (13)

Sort alphabetically

Sort by EU Contribution

Expand all

AMSTERDAM SCIENTIFIC INSTRUMENTS BV

Netherlands

EU Contribution

€ 255 374,28

EUROPEAN ORGANIZATION FOR NUCLEAR RESEARCH

Switzerland

EU Contribution

€ 265 226,76

FONDAZIONE CENTRO NAZIONALE DI ADROTERAPIA ONCOLOGICA

Italy

EU Contribution

€ 516 122,64

AGENCIA ESTATAL CONSEJO SUPERIOR DEINVESTIGACIONES CIENTIFICAS

Spain

EU Contribution

€ 247 872,96

GSI HELMHOLTZZENTRUM FUER SCHWERIONENFORSCHUNG GMBH

Germany

EU Contribution

€ 249 216,48

ION BEAM APPLICATIONS SA

Belgium

EU Contribution

€ 250 560

LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN

Germany

EU Contribution

€ 249 216,48

EBG (Entwicklungs- und Betriebsgesellschaft) MedAustron GmbH

Austria

EU Contribution

€ 255 934,08

PAUL SCHERRER INSTITUT

Switzerland

EU Contribution

€ 265 226,76

UNIVERSITY COLLEGE LONDON

United Kingdom

EU Contribution

€ 273 287,88

THE UNIVERSITY OF MANCHESTER

United Kingdom

EU Contribution

€ 273 287,88

UNIVERSIDAD DE SEVILLA

Spain

EU Contribution

€ 247 872,96

VIALUX MESSTECHNIK + BILDVERARBEITUNG GMBH

Germany

EU Contribution

€ 249 216,48

Partners (10)

Sort alphabetically

Expand all

Clatterbridge Cancer Centre

The Christie

COSYLAB LABORATORIJ ZA KONTROLNE SISTEME DD

Fistral Training and Consultancy Ltd.

Holdsworth Associates

ISTITUTO NAZIONALE DI FISICA NUCLEARE

INVENTYA LTD

SCIENCE AND TECHNOLOGY FACILITIES COUNCIL

UK Intellectual Property Office

UNIVERSITY OF LANCASTER

Project information

Grant agreement ID: 675265

Status

Ongoing project

  • Start date

    1 February 2016

  • End date

    31 January 2020

Funded under:

H2020-EU.1.3.1.

  • Overall budget:

    € 3 871 703,52

  • EU contribution

    € 3 871 703,52

Coordinated by:

THE UNIVERSITY OF LIVERPOOL

United Kingdom